Starpharma Holdings Ltd. (SPHRY)
5.05
-0.80
(-13.68%)
USD |
OTCM |
Oct 02, 16:00
Starpharma Holdings Market Cap : 218.20M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 218.20M |
| October 01, 2026 | 252.76M |
| September 30, 2026 | 252.76M |
| September 29, 2026 | 244.21M |
| September 28, 2026 | 246.82M |
| September 25, 2026 | 248.44M |
| September 24, 2026 | 223.81M |
| September 23, 2026 | 235.69M |
| September 22, 2026 | 225.54M |
| September 21, 2026 | 226.40M |
| September 18, 2026 | 239.80M |
| September 17, 2026 | 231.59M |
| September 16, 2026 | 231.59M |
| September 15, 2026 | 218.20M |
| September 14, 2026 | 218.20M |
| September 11, 2026 | 218.20M |
| September 10, 2026 | 231.16M |
| September 09, 2026 | 231.16M |
| September 08, 2026 | 250.60M |
| September 04, 2026 | 224.68M |
| September 03, 2026 | 224.68M |
| September 02, 2026 | 229.00M |
| September 01, 2026 | 229.00M |
| August 31, 2026 | 229.00M |
| August 28, 2026 | 229.00M |
| Date | Value |
|---|---|
| August 27, 2026 | 216.04M |
| August 26, 2026 | 216.04M |
| August 25, 2026 | 217.12M |
| August 24, 2026 | 209.99M |
| August 21, 2026 | 233.32M |
| August 20, 2026 | 232.76M |
| August 19, 2026 | 213.36M |
| August 18, 2026 | 224.14M |
| August 17, 2026 | 224.14M |
| August 14, 2026 | 224.14M |
| August 13, 2026 | 232.76M |
| August 12, 2026 | 232.76M |
| August 11, 2026 | 232.76M |
| August 10, 2026 | 232.76M |
| August 07, 2026 | 228.45M |
| August 06, 2026 | 222.84M |
| August 05, 2026 | 222.84M |
| August 04, 2026 | 204.31M |
| August 03, 2026 | 200.00M |
| July 31, 2026 | 210.69M |
| July 30, 2026 | 210.69M |
| July 29, 2026 | 202.15M |
| July 28, 2026 | 202.15M |
| July 27, 2026 | 198.96M |
| July 24, 2026 | 198.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Percheron Therapeutics Ltd. | 3.654M |
| Neuren Pharmaceuticals Ltd. | 1.810B |
| Mayne Pharma Group Ltd. | 162.49M |
| Acrux Ltd. | 1.725M |
| Zelira Therapeutics Ltd. | 3.093M |
Market Cap Related Metrics
| PS Ratio | 27.37 |
| Price | 5.05 |
| Earnings Yield | -2.43% |